Abstract1,2,4‐Triazole‐fluoroquinolone and 1,2,4‐triazole–conazole hybrids are designed, synthesized, and investigated in vitro against a variety of common diseases. The structure of the newly synthesized compounds are characterized from spectral data (IR, 1H NMR, 13C NMR, and LC–MS). The antibacterial activity against both Gram‐positive and Gram‐negative bacteria is shown to be enhanced by many of the produced compounds. Also, some of the products are found to have strong antiproliferative effects aganist HeLa cervical cancer cells, whilst demonstrating cytotoxic effects toward normal cells.